An approach to implementing patient and public involvement in investigator-initiated clinical trials
As patient and public involvement (PPI) in academic clinical research, especially clinical trials, is gaining recognition, including acceptance and implementation, questions arise about how to establish an effective “basic framework for PPI in academic clinical research” for all stakeholders in Sw...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2025-06-01
|
| Series: | Swiss Medical Weekly |
| Online Access: | https://smw.ch/index.php/smw/article/view/4563 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849684815590195200 |
|---|---|
| author | Kristin Marie Bivens Amélie J. A. A. Guyon Valerie Behan Eva Segelov |
| author_facet | Kristin Marie Bivens Amélie J. A. A. Guyon Valerie Behan Eva Segelov |
| author_sort | Kristin Marie Bivens |
| collection | DOAJ |
| description |
As patient and public involvement (PPI) in academic clinical research, especially clinical trials, is gaining recognition, including acceptance and implementation, questions arise about how to establish an effective “basic framework for PPI in academic clinical research” for all stakeholders in Switzerland. In this Viewpoint, the authors focus on one aspect of the survey and interview results reported by Eberle and colleagues from PPI contributors, researchers, academic research infrastructure staff, and representatives of regulatory and funding bodies to identify a possible direction for a basic PPI framework in Switzerland. Specifically, they describe how they prepare two groups of stakeholders – clinical researchers and PPI contributors – for collaboration. They present clear definitional distinctions to help clinical researchers prepare for the 2025 call for proposals from the Swiss National Science Foundation (SNSF) for Investigator-Initiated Clinical Trials (IICT) and provide important background information that is essential for understanding the fundamentals of PPI.
|
| format | Article |
| id | doaj-art-789d8e67eb2b48bcb8e59f540a5196f6 |
| institution | DOAJ |
| issn | 1424-3997 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | SMW supporting association (Trägerverein Swiss Medical Weekly SMW) |
| record_format | Article |
| series | Swiss Medical Weekly |
| spelling | doaj-art-789d8e67eb2b48bcb8e59f540a5196f62025-08-20T03:23:20ZengSMW supporting association (Trägerverein Swiss Medical Weekly SMW)Swiss Medical Weekly1424-39972025-06-01155610.57187/s.4563An approach to implementing patient and public involvement in investigator-initiated clinical trialsKristin Marie Bivens0Amélie J. A. A. GuyonValerie BehanEva SegelovUniversity of Bern As patient and public involvement (PPI) in academic clinical research, especially clinical trials, is gaining recognition, including acceptance and implementation, questions arise about how to establish an effective “basic framework for PPI in academic clinical research” for all stakeholders in Switzerland. In this Viewpoint, the authors focus on one aspect of the survey and interview results reported by Eberle and colleagues from PPI contributors, researchers, academic research infrastructure staff, and representatives of regulatory and funding bodies to identify a possible direction for a basic PPI framework in Switzerland. Specifically, they describe how they prepare two groups of stakeholders – clinical researchers and PPI contributors – for collaboration. They present clear definitional distinctions to help clinical researchers prepare for the 2025 call for proposals from the Swiss National Science Foundation (SNSF) for Investigator-Initiated Clinical Trials (IICT) and provide important background information that is essential for understanding the fundamentals of PPI. https://smw.ch/index.php/smw/article/view/4563 |
| spellingShingle | Kristin Marie Bivens Amélie J. A. A. Guyon Valerie Behan Eva Segelov An approach to implementing patient and public involvement in investigator-initiated clinical trials Swiss Medical Weekly |
| title | An approach to implementing patient and public involvement in investigator-initiated clinical trials |
| title_full | An approach to implementing patient and public involvement in investigator-initiated clinical trials |
| title_fullStr | An approach to implementing patient and public involvement in investigator-initiated clinical trials |
| title_full_unstemmed | An approach to implementing patient and public involvement in investigator-initiated clinical trials |
| title_short | An approach to implementing patient and public involvement in investigator-initiated clinical trials |
| title_sort | approach to implementing patient and public involvement in investigator initiated clinical trials |
| url | https://smw.ch/index.php/smw/article/view/4563 |
| work_keys_str_mv | AT kristinmariebivens anapproachtoimplementingpatientandpublicinvolvementininvestigatorinitiatedclinicaltrials AT ameliejaaguyon anapproachtoimplementingpatientandpublicinvolvementininvestigatorinitiatedclinicaltrials AT valeriebehan anapproachtoimplementingpatientandpublicinvolvementininvestigatorinitiatedclinicaltrials AT evasegelov anapproachtoimplementingpatientandpublicinvolvementininvestigatorinitiatedclinicaltrials AT kristinmariebivens approachtoimplementingpatientandpublicinvolvementininvestigatorinitiatedclinicaltrials AT ameliejaaguyon approachtoimplementingpatientandpublicinvolvementininvestigatorinitiatedclinicaltrials AT valeriebehan approachtoimplementingpatientandpublicinvolvementininvestigatorinitiatedclinicaltrials AT evasegelov approachtoimplementingpatientandpublicinvolvementininvestigatorinitiatedclinicaltrials |